Yasmin oral contraceptive associated with slightly higher VTE risk than previously thought

摘要

Ethinylestradiol and drospirenone (Yasmin; Bayer) oral contraceptive is associated with a slightly higher risk of venous thromboembolism (VTE) than previously thought, according to the Medicines and Healthcare products Regulatory Agency's latest Drug Safety Update, published this month.